GB0714129D0 - compounds - Google Patents
compoundsInfo
- Publication number
- GB0714129D0 GB0714129D0 GBGB0714129.4A GB0714129A GB0714129D0 GB 0714129 D0 GB0714129 D0 GB 0714129D0 GB 0714129 A GB0714129 A GB 0714129A GB 0714129 D0 GB0714129 D0 GB 0714129D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0714129.4A GB0714129D0 (en) | 2007-07-19 | 2007-07-19 | compounds |
PCT/EP2008/059387 WO2009010560A1 (en) | 2007-07-19 | 2008-07-17 | Pyrazole derivatives and use thereof as inhibitors of stearoyl-coa desaturase |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0714129.4A GB0714129D0 (en) | 2007-07-19 | 2007-07-19 | compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0714129D0 true GB0714129D0 (en) | 2007-08-29 |
Family
ID=38476650
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0714129.4A Ceased GB0714129D0 (en) | 2007-07-19 | 2007-07-19 | compounds |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0714129D0 (en) |
WO (1) | WO2009010560A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0722077D0 (en) | 2007-11-09 | 2007-12-19 | Smithkline Beecham Corp | Compounds |
GB0722075D0 (en) | 2007-11-09 | 2007-12-19 | Smithkline Beecham Corp | Compounds |
AU2011238616B2 (en) | 2010-03-30 | 2016-08-04 | Verseon Corporation | Multisubstituted aromatic compounds as inhibitors of thrombin |
WO2013056148A2 (en) | 2011-10-15 | 2013-04-18 | Genentech, Inc. | Methods of using scd1 antagonists |
EP3421036B8 (en) | 2013-03-15 | 2020-12-30 | Verseon International Corporation | Multisubstituted aromatic compounds as serine protease inhibitors |
MX2015011567A (en) | 2013-03-15 | 2016-04-25 | Verseon Corp | Halogenopyrazoles as inhibitors of thrombin. |
JP2017528486A (en) | 2014-09-17 | 2017-09-28 | ヴァーセオン コーポレイション | Pyrazolyl-substituted pyridone compounds as serine protease inhibitors |
KR20170122767A (en) | 2015-02-27 | 2017-11-06 | 베르선 코포레이션 | Substituted pyrazole compounds as serine protease inhibitors |
KR20190108118A (en) | 2017-01-06 | 2019-09-23 | 유마니티 테라퓨틱스, 인크. | Methods for the Treatment of Nervous System Disorders |
CA3083000A1 (en) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | Compounds and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2580845A1 (en) * | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
EP2269610A3 (en) * | 2004-09-20 | 2011-03-09 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
GB0508472D0 (en) * | 2005-04-26 | 2005-06-01 | Glaxo Group Ltd | Compounds |
GB0625654D0 (en) * | 2006-12-21 | 2007-01-31 | Smithkline Beecham Corp | Compounds |
GB0625605D0 (en) * | 2006-12-21 | 2007-01-31 | Smithkline Beecham Corp | Compounds |
GB0625604D0 (en) * | 2006-12-21 | 2007-01-31 | Smithkline Beecham Corp | Compounds |
-
2007
- 2007-07-19 GB GBGB0714129.4A patent/GB0714129D0/en not_active Ceased
-
2008
- 2008-07-17 WO PCT/EP2008/059387 patent/WO2009010560A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2009010560A1 (en) | 2009-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0706793D0 (en) | Compounds | |
GB0704407D0 (en) | Compounds | |
GB0704394D0 (en) | Compounds | |
GB0705672D0 (en) | Compounds | |
GB0714129D0 (en) | compounds | |
GB0706173D0 (en) | Compounds | |
GB0707092D0 (en) | Compounds | |
GB0706165D0 (en) | Compounds | |
GB0706168D0 (en) | Compounds | |
GB0706188D0 (en) | Compounds | |
GB0707034D0 (en) | Compounds | |
GB0706167D0 (en) | Compounds | |
GB0706174D0 (en) | Compounds | |
GB0706189D0 (en) | Compounds | |
GB0706187D0 (en) | Compounds | |
GB0706190D0 (en) | Compounds | |
GB0706164D0 (en) | Compounds | |
GB0706170D0 (en) | Compounds | |
GB0704939D0 (en) | Compounds | |
GB0703756D0 (en) | Compounds | |
GB0701985D0 (en) | Compounds | |
GB0705800D0 (en) | Compounds | |
GB0703906D0 (en) | Compounds | |
GB0706176D0 (en) | Compounds | |
GB0701955D0 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |